CN104450374B - 一种黄秋葵、菌、藻组合物保健酒及其制备方法 - Google Patents
一种黄秋葵、菌、藻组合物保健酒及其制备方法 Download PDFInfo
- Publication number
- CN104450374B CN104450374B CN201410571574.4A CN201410571574A CN104450374B CN 104450374 B CN104450374 B CN 104450374B CN 201410571574 A CN201410571574 A CN 201410571574A CN 104450374 B CN104450374 B CN 104450374B
- Authority
- CN
- China
- Prior art keywords
- bacterium
- abelmoschus esculentus
- algae
- health promoting
- days
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 240000004507 Abelmoschus esculentus Species 0.000 title claims abstract description 30
- 235000003934 Abelmoschus esculentus Nutrition 0.000 title claims abstract description 30
- 239000000203 mixture Substances 0.000 title claims abstract description 30
- 241000894006 Bacteria Species 0.000 title claims abstract description 25
- 241000195493 Cryptophyta Species 0.000 title claims abstract description 25
- 230000001737 promoting Effects 0.000 title claims abstract description 18
- 238000002360 preparation method Methods 0.000 title claims abstract description 13
- 150000001875 compounds Chemical class 0.000 claims abstract description 13
- 238000002156 mixing Methods 0.000 claims abstract description 10
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims abstract description 9
- 235000021329 brown rice Nutrition 0.000 claims abstract description 8
- 238000003825 pressing Methods 0.000 claims abstract description 8
- 239000000463 material Substances 0.000 claims abstract description 7
- 239000002994 raw material Substances 0.000 claims abstract description 7
- 238000004140 cleaning Methods 0.000 claims abstract description 6
- 239000007788 liquid Substances 0.000 claims abstract description 6
- 238000000855 fermentation Methods 0.000 claims abstract description 5
- 230000004151 fermentation Effects 0.000 claims abstract description 5
- 238000001816 cooling Methods 0.000 claims abstract description 4
- 238000011049 filling Methods 0.000 claims abstract description 4
- 238000001914 filtration Methods 0.000 claims abstract description 4
- 239000002244 precipitate Substances 0.000 claims abstract description 4
- 230000001523 saccharolytic Effects 0.000 claims abstract description 4
- 241001264174 Cordyceps militaris Species 0.000 claims description 8
- 240000002900 Arthrospira platensis Species 0.000 claims description 7
- 235000016425 Arthrospira platensis Nutrition 0.000 claims description 7
- 229940082787 Spirulina Drugs 0.000 claims description 7
- 238000000034 method Methods 0.000 claims description 4
- 238000000227 grinding Methods 0.000 claims description 2
- 238000007598 dipping method Methods 0.000 abstract 1
- 238000010298 pulverizing process Methods 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 23
- 201000010099 disease Diseases 0.000 description 18
- 240000000588 Hericium erinaceus Species 0.000 description 15
- 235000007328 Hericium erinaceus Nutrition 0.000 description 15
- 235000005911 diet Nutrition 0.000 description 14
- 235000013305 food Nutrition 0.000 description 13
- 241000222336 Ganoderma Species 0.000 description 11
- 230000000378 dietary Effects 0.000 description 11
- 235000018102 proteins Nutrition 0.000 description 11
- 102000004169 proteins and genes Human genes 0.000 description 11
- 108090000623 proteins and genes Proteins 0.000 description 11
- 239000003814 drug Substances 0.000 description 10
- 235000019197 fats Nutrition 0.000 description 10
- 238000002560 therapeutic procedure Methods 0.000 description 10
- HVYWMOMLDIMFJA-DPAQBDIFSA-N (3β)-Cholest-5-en-3-ol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 9
- 241000196324 Embryophyta Species 0.000 description 9
- 210000004369 Blood Anatomy 0.000 description 8
- 210000003491 Skin Anatomy 0.000 description 8
- 235000001014 amino acid Nutrition 0.000 description 8
- 239000008280 blood Substances 0.000 description 8
- 239000011575 calcium Substances 0.000 description 8
- 229910052791 calcium Inorganic materials 0.000 description 8
- 150000001413 amino acids Chemical class 0.000 description 7
- OYPRJOBELJOOCE-UHFFFAOYSA-N calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 7
- 235000001465 calcium Nutrition 0.000 description 7
- 150000004676 glycans Polymers 0.000 description 6
- 229920001282 polysaccharide Polymers 0.000 description 6
- 239000005017 polysaccharide Substances 0.000 description 6
- 150000004804 polysaccharides Polymers 0.000 description 6
- 206010003549 Asthenia Diseases 0.000 description 5
- 208000007443 Neurasthenia Diseases 0.000 description 5
- 241001619461 Poria <basidiomycete fungus> Species 0.000 description 5
- 229940088594 Vitamin Drugs 0.000 description 5
- 239000002253 acid Substances 0.000 description 5
- 230000001093 anti-cancer Effects 0.000 description 5
- 201000011510 cancer Diseases 0.000 description 5
- 230000036039 immunity Effects 0.000 description 5
- 239000011630 iodine Substances 0.000 description 5
- 229910052740 iodine Inorganic materials 0.000 description 5
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 5
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 5
- 230000001629 suppression Effects 0.000 description 5
- 150000003648 triterpenes Chemical class 0.000 description 5
- 235000013311 vegetables Nutrition 0.000 description 5
- 235000013343 vitamin Nutrition 0.000 description 5
- 239000011782 vitamin Substances 0.000 description 5
- 150000003722 vitamin derivatives Chemical class 0.000 description 5
- 229930003231 vitamins Natural products 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 229940107161 Cholesterol Drugs 0.000 description 4
- 208000007882 Gastritis Diseases 0.000 description 4
- 210000001035 Gastrointestinal Tract Anatomy 0.000 description 4
- 208000007107 Stomach Ulcer Diseases 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- 230000032683 aging Effects 0.000 description 4
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 4
- 230000003796 beauty Effects 0.000 description 4
- 150000001746 carotenes Chemical class 0.000 description 4
- 235000005473 carotenes Nutrition 0.000 description 4
- 235000012000 cholesterol Nutrition 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 4
- DHMQDGOQFOQNFH-UHFFFAOYSA-N glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
- PVNIIMVLHYAWGP-UHFFFAOYSA-N nicotinic acid Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 4
- 229910052698 phosphorus Inorganic materials 0.000 description 4
- 230000002265 prevention Effects 0.000 description 4
- DTOSIQBPPRVQHS-PDBXOOCHSA-N α-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 4
- 206010017758 Gastric cancer Diseases 0.000 description 3
- 206010062717 Increased upper airway secretion Diseases 0.000 description 3
- 210000000214 Mouth Anatomy 0.000 description 3
- IPCSVZSSVZVIGE-UHFFFAOYSA-N Palmitic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 3
- 229930003779 Vitamin B12 Natural products 0.000 description 3
- 230000036772 blood pressure Effects 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 235000014633 carbohydrates Nutrition 0.000 description 3
- 125000003346 cobalamin group Chemical group 0.000 description 3
- 229910052802 copper Inorganic materials 0.000 description 3
- 239000010949 copper Substances 0.000 description 3
- 229920003013 deoxyribonucleic acid Polymers 0.000 description 3
- 230000037213 diet Effects 0.000 description 3
- 230000029087 digestion Effects 0.000 description 3
- 235000013399 edible fruits Nutrition 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 235000013376 functional food Nutrition 0.000 description 3
- 201000005917 gastric ulcer Diseases 0.000 description 3
- 210000000056 organs Anatomy 0.000 description 3
- 229910052700 potassium Inorganic materials 0.000 description 3
- 230000001105 regulatory Effects 0.000 description 3
- 229960003471 retinol Drugs 0.000 description 3
- 229910052711 selenium Inorganic materials 0.000 description 3
- 239000011669 selenium Substances 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 201000011549 stomach cancer Diseases 0.000 description 3
- 235000019163 vitamin B12 Nutrition 0.000 description 3
- 239000011715 vitamin B12 Substances 0.000 description 3
- DBTMGCOVALSLOR-DEVYUCJPSA-N (2S,3R,4S,5R,6R)-4-[(2S,3R,4S,5R,6R)-3,5-dihydroxy-6-(hydroxymethyl)-4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-6-(hydroxymethyl)oxane-2,3,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](CO)O[C@H](O)[C@@H]2O)O)O[C@H](CO)[C@H]1O DBTMGCOVALSLOR-DEVYUCJPSA-N 0.000 description 2
- 229960003767 Alanine Drugs 0.000 description 2
- 241000512259 Ascophyllum nodosum Species 0.000 description 2
- 206010006187 Breast cancer Diseases 0.000 description 2
- 229960001231 Choline Drugs 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N D-Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 208000002173 Dizziness Diseases 0.000 description 2
- 208000000718 Duodenal Ulcer Diseases 0.000 description 2
- 229940088598 Enzyme Drugs 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 241000628997 Flos Species 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- 229960001031 Glucose Drugs 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- 229960002449 Glycine Drugs 0.000 description 2
- 240000001340 Gmelina philippensis Species 0.000 description 2
- 206010018498 Goitre Diseases 0.000 description 2
- 229960002885 Histidine Drugs 0.000 description 2
- 241000577951 Hydnum Species 0.000 description 2
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 2
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 2
- 229920001543 Laminarin Polymers 0.000 description 2
- OYHQOLUKZRVURQ-IXWMQOLASA-N Linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 2
- 229960004488 Linolenic Acid Drugs 0.000 description 2
- 240000003183 Manihot esculenta Species 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 206010030155 Oesophageal carcinoma Diseases 0.000 description 2
- 206010033307 Overweight Diseases 0.000 description 2
- 241000283898 Ovis Species 0.000 description 2
- VDYCLYGKCGVBHN-DRCQUEPLSA-N Pachymic acid Chemical compound C([C@@]12C)C[C@H](OC(C)=O)C(C)(C)[C@@H]1CCC1=C2CC[C@]2(C)[C@@H]([C@@H](CCC(=C)C(C)C)C(O)=O)[C@H](O)C[C@]21C VDYCLYGKCGVBHN-DRCQUEPLSA-N 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 241000206607 Porphyra umbilicalis Species 0.000 description 2
- 229960002429 Proline Drugs 0.000 description 2
- AUNGANRZJHBGPY-OUCADQQQSA-N Riboflavin Natural products OC[C@@H](O)[C@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-OUCADQQQSA-N 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- 229960002477 Riboflavin Drugs 0.000 description 2
- 206010039966 Senile dementia Diseases 0.000 description 2
- 210000000952 Spleen Anatomy 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N Stearic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- 206010068760 Ulcers Diseases 0.000 description 2
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 2
- 229940045997 Vitamin A Drugs 0.000 description 2
- 235000004279 alanine Nutrition 0.000 description 2
- 235000013334 alcoholic beverage Nutrition 0.000 description 2
- 235000010443 alginic acid Nutrition 0.000 description 2
- 229920000615 alginic acid Polymers 0.000 description 2
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 2
- 230000003712 anti-aging Effects 0.000 description 2
- 230000000259 anti-tumor Effects 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 201000008275 breast carcinoma Diseases 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 201000009030 carcinoma Diseases 0.000 description 2
- 210000004027 cells Anatomy 0.000 description 2
- CRBHXDCYXIISFC-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CC[O-] CRBHXDCYXIISFC-UHFFFAOYSA-N 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 235000013325 dietary fiber Nutrition 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000002708 enhancing Effects 0.000 description 2
- 201000005619 esophageal carcinoma Diseases 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 239000000446 fuel Substances 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 235000013402 health food Nutrition 0.000 description 2
- 230000002443 hepatoprotective Effects 0.000 description 2
- 235000008216 herbs Nutrition 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 229910052748 manganese Inorganic materials 0.000 description 2
- 239000011572 manganese Substances 0.000 description 2
- 235000005739 manihot Nutrition 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- OKKJLVBELUTLKV-UHFFFAOYSA-N methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 2
- 235000001968 nicotinic acid Nutrition 0.000 description 2
- 229960003512 nicotinic acid Drugs 0.000 description 2
- 239000011664 nicotinic acid Substances 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 235000020825 overweight Nutrition 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 235000014786 phosphorus Nutrition 0.000 description 2
- 230000035479 physiological effects, processes and functions Effects 0.000 description 2
- 230000025627 positive regulation of urine volume Effects 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- 230000003405 preventing Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 235000013930 proline Nutrition 0.000 description 2
- -1 proline Aminoacid Chemical class 0.000 description 2
- 230000002829 reduced Effects 0.000 description 2
- 235000019192 riboflavin Nutrition 0.000 description 2
- 239000002151 riboflavin Substances 0.000 description 2
- 229920002477 rna polymer Polymers 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- BUGBHKTXTAQXES-UHFFFAOYSA-N selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 2
- KEAYESYHFKHZAL-UHFFFAOYSA-N sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 235000014347 soups Nutrition 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 230000002194 synthesizing Effects 0.000 description 2
- 230000001256 tonic Effects 0.000 description 2
- 230000001131 transforming Effects 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 2
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 2
- 235000019155 vitamin A Nutrition 0.000 description 2
- 239000011719 vitamin A Substances 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- DWNBOPVKNPVNQG-LURJTMIESA-N (2S)-4-hydroxy-2-(propylamino)butanoic acid Chemical compound CCCN[C@H](C(O)=O)CCO DWNBOPVKNPVNQG-LURJTMIESA-N 0.000 description 1
- HYRUXGRHTJRKNG-SMBWEDIMSA-N (2S,3R,4R,5R,6R)-2-[(2R,3R,4R,5R,6S)-6-[(2R,3R,4R,5R,6R)-4,5-dihydroxy-2-(hydroxymethyl)-6-methoxyoxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)-5-methoxyoxane-3,4-diol Chemical compound O[C@@H]1[C@@H](O)[C@H](OC)O[C@H](CO)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H](O[C@H]2[C@@H]([C@@H](O)[C@@H](OC)[C@@H](CO)O2)O)[C@@H](CO)O1 HYRUXGRHTJRKNG-SMBWEDIMSA-N 0.000 description 1
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 241001075517 Abelmoschus Species 0.000 description 1
- 206010049865 Achromotrichia acquired Diseases 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 229960000643 Adenine Drugs 0.000 description 1
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Natural products NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
- 208000005584 Alcoholic Intoxication Diseases 0.000 description 1
- 206010001897 Alzheimer's disease Diseases 0.000 description 1
- 208000007502 Anemia Diseases 0.000 description 1
- 208000002399 Aphthous Stomatitis Diseases 0.000 description 1
- 206010059512 Apoptosis Diseases 0.000 description 1
- 241001495180 Arthrospira Species 0.000 description 1
- 229960005261 Aspartic Acid Drugs 0.000 description 1
- 206010064097 Avian influenza Diseases 0.000 description 1
- 206010005003 Bladder cancer Diseases 0.000 description 1
- 210000001185 Bone Marrow Anatomy 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 210000004556 Brain Anatomy 0.000 description 1
- 208000005882 Cadmium Poisoning Diseases 0.000 description 1
- 206010006956 Calcium deficiency Diseases 0.000 description 1
- 240000001452 Canavalia ensiformis Species 0.000 description 1
- 208000005623 Carcinogenesis Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- DJHJJVWPFGHIPH-OODMECLYSA-N Chitin Chemical compound O[C@@H]1C(NC(=O)C)[C@H](O)OC(CO)[C@H]1COC[C@H]1C(NC(C)=O)[C@@H](O)[C@H](COC[C@H]2C([C@@H](O)[C@H](O)C(CO)O2)NC(C)=O)C(CO)O1 DJHJJVWPFGHIPH-OODMECLYSA-N 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 241000209020 Cornus Species 0.000 description 1
- 210000003792 Cranial Nerves Anatomy 0.000 description 1
- FBPFZTCFMRRESA-KAZBKCHUSA-N D-Mannitol Natural products OC[C@@H](O)[C@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KAZBKCHUSA-N 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 102000033147 ERVK-25 Human genes 0.000 description 1
- 229960005135 Eicosapentaenoic Acid Drugs 0.000 description 1
- JAZBEHYOTPTENJ-JLNKQSITSA-N Eicosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 description 1
- 210000003743 Erythrocytes Anatomy 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- 210000000416 Exudates and Transudates Anatomy 0.000 description 1
- 206010016766 Flatulence Diseases 0.000 description 1
- 210000004211 Gastric Acid Anatomy 0.000 description 1
- 229960002989 Glutamic Acid Drugs 0.000 description 1
- 241000590002 Helicobacter pylori Species 0.000 description 1
- 229940037467 Helicobacter pylori Drugs 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 102220370181 IGFBPL1 A23L Human genes 0.000 description 1
- 229960000310 ISOLEUCINE Drugs 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010067997 Iodine deficiency Diseases 0.000 description 1
- 210000003734 Kidney Anatomy 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- 239000005717 Laminarin Substances 0.000 description 1
- 229940067606 Lecithin Drugs 0.000 description 1
- 206010024324 Leukaemias Diseases 0.000 description 1
- 210000000265 Leukocytes Anatomy 0.000 description 1
- 229940040461 Lipase Drugs 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 210000004185 Liver Anatomy 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 210000004698 Lymphocytes Anatomy 0.000 description 1
- 206010025323 Lymphomas Diseases 0.000 description 1
- 210000002540 Macrophages Anatomy 0.000 description 1
- 206010057840 Major depression Diseases 0.000 description 1
- 206010025650 Malignant melanoma Diseases 0.000 description 1
- 241000219071 Malvaceae Species 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- JDSHMPZPIAZGSV-UHFFFAOYSA-N Melamine Chemical compound NC1=NC(N)=NC(N)=N1 JDSHMPZPIAZGSV-UHFFFAOYSA-N 0.000 description 1
- 230000036740 Metabolism Effects 0.000 description 1
- 210000004080 Milk Anatomy 0.000 description 1
- 210000003097 Mucus Anatomy 0.000 description 1
- 210000003205 Muscles Anatomy 0.000 description 1
- 208000002454 Nasopharyngeal Carcinoma Diseases 0.000 description 1
- 206010061306 Nasopharyngeal cancer Diseases 0.000 description 1
- 240000002853 Nelumbo nucifera Species 0.000 description 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 1
- 206010052242 Nephroangiosclerosis Diseases 0.000 description 1
- 206010025310 Other lymphomas Diseases 0.000 description 1
- 210000003254 Palate Anatomy 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 210000003899 Penis Anatomy 0.000 description 1
- 108091005771 Peptidases Proteins 0.000 description 1
- 235000010617 Phaseolus lunatus Nutrition 0.000 description 1
- 240000005158 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 231100000614 Poison Toxicity 0.000 description 1
- 241000206609 Porphyra Species 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 244000299790 Rheum rhabarbarum Species 0.000 description 1
- 235000009411 Rheum rhabarbarum Nutrition 0.000 description 1
- 241000315672 SARS coronavirus Species 0.000 description 1
- 101710002423 SOD1 Proteins 0.000 description 1
- 101710002416 SOD3 Proteins 0.000 description 1
- 101710013084 SODCC1 Proteins 0.000 description 1
- 210000000582 Semen Anatomy 0.000 description 1
- BNRNXUUZRGQAQC-UHFFFAOYSA-N Sildenafil Chemical compound CCCC1=NN(C)C(C(N2)=O)=C1N=C2C(C(=CC=1)OCC)=CC=1S(=O)(=O)N1CCN(C)CC1 BNRNXUUZRGQAQC-UHFFFAOYSA-N 0.000 description 1
- 210000002356 Skeleton Anatomy 0.000 description 1
- 229940005550 Sodium alginate Drugs 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- JIWBIWFOSCKQMA-LTKCOYKYSA-N Stearidonic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/CCCCC(O)=O JIWBIWFOSCKQMA-LTKCOYKYSA-N 0.000 description 1
- 210000002784 Stomach Anatomy 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 102000019197 Superoxide Dismutase Human genes 0.000 description 1
- 108010012715 Superoxide Dismutase Proteins 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- 210000001685 Thyroid Gland Anatomy 0.000 description 1
- 206010043966 Tongue neoplasm malignant stage unspecified Diseases 0.000 description 1
- 241001506047 Tremella Species 0.000 description 1
- 240000008529 Triticum aestivum Species 0.000 description 1
- 210000002700 Urine Anatomy 0.000 description 1
- 229940094720 Viagra Drugs 0.000 description 1
- 240000004922 Vigna radiata Species 0.000 description 1
- 235000010721 Vigna radiata var radiata Nutrition 0.000 description 1
- 235000011469 Vigna radiata var sublobata Nutrition 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 1
- 238000009098 adjuvant therapy Methods 0.000 description 1
- 231100000360 alopecia Toxicity 0.000 description 1
- 201000004384 alopecia Diseases 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000003266 anti-allergic Effects 0.000 description 1
- 230000001088 anti-asthma Effects 0.000 description 1
- 230000000844 anti-bacterial Effects 0.000 description 1
- 230000000118 anti-eoplastic Effects 0.000 description 1
- 230000003064 anti-oxidating Effects 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 239000003613 bile acid Substances 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- BDOSMKKIYDKNTQ-UHFFFAOYSA-N cadmium Chemical compound [Cd] BDOSMKKIYDKNTQ-UHFFFAOYSA-N 0.000 description 1
- 229910052793 cadmium Inorganic materials 0.000 description 1
- CJOBVZJTOIVNNF-UHFFFAOYSA-N cadmium sulfide Chemical compound [Cd]=S CJOBVZJTOIVNNF-UHFFFAOYSA-N 0.000 description 1
- 230000001914 calming Effects 0.000 description 1
- 230000036952 cancer formation Effects 0.000 description 1
- 230000000711 cancerogenic Effects 0.000 description 1
- 231100000504 carcinogenesis Toxicity 0.000 description 1
- 231100000315 carcinogenic Toxicity 0.000 description 1
- 230000000271 cardiovascular Effects 0.000 description 1
- 230000001925 catabolic Effects 0.000 description 1
- 230000001413 cellular Effects 0.000 description 1
- 230000002490 cerebral Effects 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000005059 dormancy Effects 0.000 description 1
- 229940079593 drugs Drugs 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 235000020673 eicosapentaenoic acid Nutrition 0.000 description 1
- 230000029578 entry into host Effects 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 230000002349 favourable Effects 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 230000002496 gastric Effects 0.000 description 1
- 201000002146 gastrointestinal system disease Diseases 0.000 description 1
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 description 1
- 229910052732 germanium Inorganic materials 0.000 description 1
- 235000001727 glucose Nutrition 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 201000010238 heart disease Diseases 0.000 description 1
- 231100000753 hepatic injury Toxicity 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 230000001146 hypoxic Effects 0.000 description 1
- 230000002519 immonomodulatory Effects 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000000968 intestinal Effects 0.000 description 1
- 230000031891 intestinal absorption Effects 0.000 description 1
- 201000002313 intestinal cancer Diseases 0.000 description 1
- 235000006479 iodine deficiency Nutrition 0.000 description 1
- 235000014705 isoleucine Nutrition 0.000 description 1
- 230000002147 killing Effects 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 201000002364 leukopenia Diseases 0.000 description 1
- 231100001022 leukopenia Toxicity 0.000 description 1
- 230000004301 light adaptation Effects 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- 102000004882 lipase Human genes 0.000 description 1
- 108090001060 lipase Proteins 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 235000004213 low-fat Nutrition 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 201000003995 melancholia Diseases 0.000 description 1
- 201000001441 melanoma Diseases 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000035786 metabolism Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011812 mixed powder Substances 0.000 description 1
- 230000004682 mucosal barrier function Effects 0.000 description 1
- 201000011216 nasopharynx carcinoma Diseases 0.000 description 1
- 229920001206 natural gum Polymers 0.000 description 1
- 230000001537 neural Effects 0.000 description 1
- 230000000926 neurological Effects 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N oxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000000242 pagocytic Effects 0.000 description 1
- 230000001717 pathogenic Effects 0.000 description 1
- 230000001575 pathological Effects 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- 230000003449 preventive Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000004224 protection Effects 0.000 description 1
- 230000001681 protective Effects 0.000 description 1
- 230000004223 radioprotective Effects 0.000 description 1
- 230000001603 reducing Effects 0.000 description 1
- 230000000754 repressing Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- 230000036186 satiety Effects 0.000 description 1
- 235000019627 satiety Nutrition 0.000 description 1
- 235000021003 saturated fats Nutrition 0.000 description 1
- 108010048734 sclerotin Proteins 0.000 description 1
- 125000003748 selenium group Chemical group *[Se]* 0.000 description 1
- 201000003176 severe acute respiratory syndrome Diseases 0.000 description 1
- 230000001568 sexual Effects 0.000 description 1
- 230000007958 sleep Effects 0.000 description 1
- MSXHSNHNTORCAW-UHFFFAOYSA-M sodium 3,4,5,6-tetrahydroxyoxane-2-carboxylate Chemical compound [Na+].OC1OC(C([O-])=O)C(O)C(O)C1O MSXHSNHNTORCAW-UHFFFAOYSA-M 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 239000010902 straw Substances 0.000 description 1
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 description 1
- 229910052712 strontium Inorganic materials 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- 201000002510 thyroid cancer Diseases 0.000 description 1
- 201000005161 thyroid carcinoma Diseases 0.000 description 1
- 230000002936 tranquilizing Effects 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 230000001228 trophic Effects 0.000 description 1
- 201000005112 urinary bladder cancer Diseases 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 150000003700 vitamin C derivatives Chemical class 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 235000021307 wheat Nutrition 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N β-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
Abstract
本发明涉及一种具有功能的保健酒,尤其涉及一种利用黄秋葵、菌、藻组合物保健酒及其制备方法。其原料组成为包括如下重量份数的组分:(黄秋葵30‑50份、菌15‑35份、藻35‑50份)组合的混合料30‑45%,糯、糙米(1:1)55‑70%;其制作保健酒的方法,包括如下步骤:取配方量糯、糙米混合,清洗浸泡8‑12h,拌入配方量的黄秋葵、菌、藻粉碎后混合料,蒸糊,冷却,糖化(接入糖化菌),发酵30天(接入酵母菌);后酵:对上述发酵料再次加入酵母菌,发酵45天,压滤;收取压滤液,沉淀3‑4天,装缸,调和(勾兑),封存24个月即成成品酒,灌瓶包装即可。
Description
技术领域
本发明涉及一种具有功能的保健酒,尤其涉及一种黄秋葵、菌、藻组合物保健酒及其制备方法。
背景技术
近年来大气、水源污染日益严重,气(象)候反常;温差、雨雪变化骤大,促使病源菌等变异加大,突发疾病(非典、禽流感等),使人体对环境的适应能力下降;加之不法、无良商人制售伪劣,添加有毒/害物质(注水肉、地沟油、三聚氰胺等等),促使人们抵抗疾病能力(免疫力)下降,处于亚健康状态,加速了疾病(癌症)发生发展和衰老的进程。
为此,我们在争取洁净的空气和水源的同时,必须要加强自身的保护,除适当锻炼运动,食品是必不可少的,而具有食疗功能的食物是人们优先选择的品种之一。
功能食品的应用是目前国内外非常重视的课题,其发展趋势也巨大而深远,随着对外的文化广泛交流,我国的“食疗”也传入了世界各地,甚至有些产品变成了国外的专利,如意大利著名的“大黄酒”,这种酒具有饭前开胃,饭后消食,次日通便的作用,经常饮用有清肠胃,延年益寿之效,这种酒的性质对我国西北地区以牛羊肉食为多的群众以及欧美人群摄入高脂肪、高蛋白等生活习惯的人群起到很好的食疗作用。美国的“杜松子酒”、法国的“斗姆酒”和“哈姆酒”等等都与我国的“食疗”医药有关,由此可见“食疗”也受世界各地人民的重视被普遍应用。据不完全统计,新加坡人(2006年)用于食疗的费用达6500万美元。
专家们预言:今后保健方面的重大突破主要不是来自医药的新发明,而是来自更加合理的饮食结构和生活方式,我们认为专家们所说的“饮食结构”其实包含了具有食疗作用的“功能食品”。
“药食同源”和“药食同用”就是我们熟知的,如我们常吃的红枣、黑芝麻、银耳、莲子等等,既是美味食品,又是治病的药物。它们内含成分具有调节人体生理平衡的作用。当人体生理发生改变(失衡)或遭到感染(病菌入侵)时就失去调节能力而患病。此时如给予相应的功能食品,就能促使其恢复调节能力,达到防病和治病的目的,如患风寒感冒,熬点生姜葱白汤喝;口舌生疮喝点绿豆汤......诸如此类,不胜枚举。
“食疗”和“食治(病)”是我国珍贵的医药遗产,早在公元前579年就发现用酒曲治肠胃病,战国前就有饮食治病的文字记载,从商周到明、清时代,专门记载饮食治病的专著有600多种,由此足证食疗的功效。
发明内容
为了得到具有食疗功能的保健酒,本发明的目的是提供一种黄秋葵、菌、藻组合物保健酒及其制备方法,解决了药食同源和滋补保健的需求。本发明中所用的植物,均含有人体所需的特殊物质,对疾病的预防、体质的提高具有明显作用,可调节人体阴阳平衡,全面滋养提高抵抗力,延缓衰老,是滋补保健良品。
本发明所用的各组合物选择依据及其成分、功能简述:
1、黄秋葵
学名Hibiacus esculengtus属锦葵科,一年生草本植物。黄秋葵又名秋葵,羊角豆,植物伟哥等,原产非洲,早在2000多年前埃及已有栽培,以后逐渐扩种(引入)美国、日本、东南亚等地,我国古代已有黄秋葵的种植,自上世纪我国江苏、山东、北京等地扩大栽种并训育成当地品种,如:北京黄秋葵、北京红秋葵等近20多个在各地栽种,如小松菜-地刀豆-黄秋葵的间(套)种,产量很多,山东将园葱和黄秋葵的间(套)种。
黄秋葵的果荚、种子、嫩叶都可作为蔬菜食用;尤其嫩果荚中含有水溶性纤维果胶、半乳聚糖、***树胶等成分的粘滑液体,具特殊的香气。还含有丰富的维生素A、Vb、Vc以及Fe、K、P、Zn、Cu等元素,其蛋白质含量达15%~26%、碳水化合物为6.4%、脂肪2%、纤维素1%每100克可提供150千焦的热量,具体成分如下表1
黄秋葵嫩荚营养成分表(每100克含量) 表1
成分名称 | 含量 | 成分名称 | 含量 | 成分名称 | 含量 |
可食部 | 88 | 水分(克) | 86.2 | 能量(千卡) | 37 |
能量(千焦) | 155 | 蛋白质(克) | 2 | 脂肪(克) | 0.1 |
碳水化合物(克) | 11 | 膳食纤维(克) | 3.9 | 胆固醇(毫克) | 0 |
灰份(克) | 0.7 | 维生素A(毫克) | 52 | 胡萝卜素(毫克) | 310 |
视黄醇(毫克) | 0 | 硫胺素(微克) | 0.05 | 核黄素(毫克) | 0.09 |
尼克酸(毫克) | 1 | 维生素C(毫克) | 4 | 维生素(T)(毫克) | 1.03 |
a-E | 0.92 | (β-γ)-E | 0.11 | δ-E | 0 |
钙(毫克) | 45 | 磷(毫克) | 65 | 钾(毫克) | 95 |
钠(毫克) | 3.9 | 镁(毫克) | 29 | 铁(毫克) | 0.1 |
锌(毫克) | 0.23 | 硒(毫克) | 0.51 | 铜(毫克) | 0.07 |
锰(毫克) | 0.28 | 碘(毫克) | 0 |
其中特别(殊)粘滑的液体能明显加强人体的精力,驱散疲劳,更能有效地刺激男性中枢神经,加速血液循环,促进新陈代谢,使全身器官微循环血管活化,尤以***海绵体......另外混有其它成分的粘液还能帮助消化,治疗胃炎、胃溃疡、心脏病、中风、骨质疏松及老年痴呆(阿尔茨海默病)症。对皮肤(尤以面部)也具有祛皱、光滑细腻之效。
2、菌类植物
2.1、蛹虫草
蛹虫草的成分功能,依据我们已获准的国家专利:
A、李祥麟等“抗衰老药物组合物及其制法”,专利号ZL02121396.8国际专利分类号:A61K 35/78;
B、李祥麟等“提高运动员体能的藻菌食品及其制备方法”,专利号ZL03153155.5国际专利分类号:A23L 1/28;
C、杨杰,李祥麟等“利用蛹虫草茧制备保健食品胶囊的方法”,专利号201210394933.4;
D、杨杰,李祥麟等“用蛹虫草茧提取物制备保健食品(疗)之营业露酒的方法”,专利号201210394729.X;
E、杨杰,李祥麟等“用蛹虫草茧提取物制备保健食品之营养料饮料及冲剂的方法”,专利号201210393512.X;
其成分功能已在上列专利内都已说明,本文不再赘述。
2.2、猴头菇
猴头菇蛋白质含量较高,每百克含蛋白质26.3克,含较高的多糖、矿物质和维生素,18种氨基酸(其中有8种是人体必须的)麸氨酸含量特别高(0.64mg/g),猴头菇含不饱和脂肪酸,能降低血胆固醇和甘油三酯含量,调节血脂,利于血液循环,是心血管患者的理想食品;多糖类物质等活性物质抑制幽门螺旋杆菌(胃癌),具有提高肌体免疫力,延缓衰老;每百克猴头含脂肪4.2克,是名副其实的高蛋白、低脂肪食品,另外还富含各种维生素和无机盐。猴头菇有增进食欲,增强胃粘膜屏障机能,提高淋巴细胞转化率,提升白细胞等作用。故可以使人体提高对疾病的免疫能力;猴头菇中含有多种氨基酸和丰富的多糖体,能助消化,对胃炎、胃癌、食道癌、胃溃疡、十二指肠溃疡等消化道疾病、浅表性胃炎、神经衰弱、眩晕、阳痿等病症具有疗效,并对治疗肠癌有辅助作用;年老体弱者食用猴头菇,有滋补强身的作用;其含有的多糖体、多肽类及脂肪物质,能抑制癌细胞中遗传物质的合成,从而预防和治疗消化道癌症和其他恶性肿瘤;猴头还是良好的滋补食品,对神经衰弱、消化道溃疡有良好疗效。在抗癌药物筛选中,发现其对皮肤、肌肉癌肿有明显抗癌功效。所以常吃猴头菇,无病可以增强抗病能力,有病可以治疗疾病的作用;据《中国药用真菌》载,猴头菇味甘、性平,能利五脏、助消化,滋补,对消化道疾病—-胃及十二指肠溃疡,神经衰弱有良好的疗效。目前已将其制成多种食品和药品。中医认为,猴头菇性平味甘,有利五脏、助消化、滋补身体等功效。20世纪70年代以来,现代医学陆续证明猴头菌有良好的药用价值,临床应用表明,猴头菇可治疗消化不良、胃溃疡、胃窦炎、胃痛、胃胀及神经衰弱等疾病。而轻度神经衰弱患者,食用猴头菇不失为较好的辅助治疗。在临床应用上面,采用猴头菇进行治疗,对于轻度或是重度神经衰弱均可取得较为显著理想的疗效。
2.3、茯苓
含茯苓酸,β-茯苓聚糖,三萜类化合物乙烯茯苓酸以及树胶,甲壳质,蛋白质,脂肪,卵磷脂,葡萄糖,腺嘌呤,组氨酸,胆碱,β-茯苓聚糖分解酶,脂肪酶,蛋白酶等,所含茯苓酸具有增强免疫力、抗肿瘤以及镇静、降血糖等的作用;茯苓中的主要成分为茯苓聚糖,含量很高。对多种细菌有抑制作用;能降胃酸,对消化道溃疡有预防效果;对肝损伤有明显的保护作用;有抗肿瘤的作用;能多方面对免疫功能进行调节;能使化疗所致白细胞减少加速回升;并有镇静的作用;主治渗湿利水,益脾和胃,宁心安神,治小便不理,水肿胀(满),痰饮呕吐,泄泻,遗精,淋浊,惊悸,健忘,降血糖等功能;抗癌,临床常用治疗食管癌、胃癌、肝癌、鼻咽癌、舌癌、乳腺癌、膀胱癌、肺癌、溃疡性黑色素瘤等癌瘤中属脾虚湿盛、痰饮内停、湿热壅结者等。
2.4、灵芝
灵芝内含K,P,Mg,Ca,Na,Fe,Cu,Mn及锗、硒等多种元素以及灵芝三萜核苷酸。氨基酸多肽、酶、多糖等,目前已从灵芝中分离出灵芝多糖200多种,其中大部分是β-葡萄聚糖、研究证实该多糖可抑制自由基的产生,增强巨噬细胞的吞噬能力,提高机体耐缺氧,增强SOD超氧化酶的活性,抑制氧自由基产生和红细胞脂质过氧化反应,提高肝、骨髓、血液合成DNA(脱氧核糖核酸)和RNA(核糖核酸)蛋白质的能力;灵芝多糖是灵芝的主要有效成分之一,具有抗肿瘤、免疫调节、降血糖、抗氧化、降血脂与抗衰老作用。灵芝所含三萜类不下百余种,其中以四环三萜类为主,灵芝的苦味与所含三萜类有关,三萜类也是灵芝的有效成分之一,对人肝癌细胞具有细胞毒作用,也能抑制组织胺的释放,具有保肝作用和具有抗过敏作用等;属于传统珍贵药材,具备很高的药用价值,经过科研机构数十年的现代药理学研究证实,灵芝对于增强人体免疫力,调节血糖,控制血压,辅助肿瘤放化疗,保肝护肝,促进睡眠等方面均具有显著疗效。
3藻类植物
3.1、螺旋藻(节旋藻)的成分功能,依据我们已获批的国家专利:
A、曾昭琪、李祥麟等“节(螺)旋藻保健食品组合物及其制法”,专利号CN94112205.0;
B、曾昭琪、李祥麟等“钝顶节(螺)旋藻蛋白及其应用”专利号:CN94109295.X;
C、李祥麟等“解酒营养料(饮料)、醒酒胶囊的制作方法,专利号:ZL200410090707.2,其成分功能已在上列专利内说明,本文不再重述。
3.2、紫菜
其蛋白质、铁、磷、钙、核黄素、胡萝卜素等含量居各种蔬菜之冠,故紫菜又有“营养宝库”的美称。每100克内含蛋白质28.2克、脂肪0.2克、碳水化合物48.5克、Ca343mg、p457mg、Fe33.2mg、胡萝卜素1.23mg、维生素B11.8mg、VB22.07mg、尼克酸5.1mg、维生素C1.0mg、碘1.8mg,现在研究证实紫菜内VA的含量是牛奶的67倍,特别是碘含量更高,这既预防地方性甲状腺肿大又可除去人体内血管壁上的胆固醇,预防心脑肾血管硬化预防白发和秃发;紫菜还具有化痰软坚、清热利水、补肾养心的功效;营养丰富,含碘量很高,可用于治疗因缺碘引起的“甲状腺肿大”,紫菜有软坚散结功能,对其它郁结积块也有用途;富含胆碱和钙、铁、能增强记忆、治疗妇女贫血、促进骨骼、牙齿的生长和保健;含有一定量的甘露醇,可作为治疗水肿的辅助食品;紫菜所含的多糖具有明显增强细胞免疫和体液免疫功能,可促进淋巴细胞转化,提高机体的免疫力;可显著降低进血清胆固醇的总含量;紫菜的有效成分对艾氏癌的抑制率53.2%,有助于脑肿瘤、乳腺癌、甲状腺癌、恶性淋巴瘤等肿瘤的防治。
营养分析:(1)蛋白质和氨基酸紫菜的生命活性物质,对于植物生命活动非常重要。食用紫菜一般蛋白质含量24%-28%,远远高于一般的蔬菜,且人体所必需的氨基酸含量多。紫菜蛋白质的组成氨基酸如丙氨酸、天冬氨酸、谷氨酸、甘氨酸、脯氨酸等中性、酸性氨基酸较多,这是所有陆生蔬菜植物所没有的特征。
2)脂肪与陆生植物相比,紫菜的脂肪含量低,多在1%以下,紫菜的脂肪中,饱和脂肪酸的软脂酸占绝大多数,约为20%;肉豆葱酸,硬脂酸含量较少,分别占2%;对人体有很好保健作用的不饱和脂肪—亚油酸、亚麻酸或十八碳四烯酸含量较多,为10%——30%,且C20以上的高度不饱和脂肪酸也有一定的含量。更优的是紫菜中被人们比喻为“脑黄金”的二十碳五烯酸含量高达30%。
(3)维生素紫菜含有多种维生素,B族维生素的含量与蔬菜相比毫不逊色。紫菜中B族维生素特别是在陆生植物中几乎不存在的维生素B12的含量很高,以干物计,维生素B12的含量与鱼肉相近,维生素C的含量也很高。维生素B12有活跃脑神经,预防衰老和记忆力衰退,改善忧郁症之功效。
(4)无机质由于海水蕴含极为丰富的无机成份,而紫菜又具有吸收和积蓄海水中无机质的功能,因些紫菜中的无机质含量极为丰富。
3.3、海带
海带含有人体多种必须的蛋白质、氨基酸、脯氨酸、异亮氨酸、丙氨酸、甘氨酸等维生素B120.7ug%、B2810mg%胡萝卜素0.77%、水溶性氯化钾、碘、钙、溴、藻胶酸、昆布素、甘露醇、无机盐、有机酸、亚麻酸甲醇、植物醇、棕榈酸、岩藻甾醇、天羁萜、里麦草内脂、多糖等,药理:1、可纠正甲状腺机能不足;2、可促进病理产物(炎症)渗出物的吸收;3、降血压:海带氨酸及钾盐、钙元素可降低人体对胆固醇的吸收,降低血压;4、平喘镇咳;5、补钙:海带含有丰富的钙,可防治人体缺钙;6、美容:海带汁可以美容养颜,用海带熬成的汤汁泡澡,可以润泽肌肤,使皮肤清爽细滑,光洁美丽;7、减肥:海带含有大量的膳食纤维,可以增加肥胖者的饱腹感,而且海带脂肪含量非常低,热量小,是肥胖者减肥的食物;8、延缓衰老:海带富含有硒,能有效清除自由基,而自由基正是人体衰老的罪魁祸首,所以海带可以延缓衰老的作用。9、抑制癌细胞;海带所含的海藻酸钠与具致癌作用的锶、镉有很强的结合能力,并将它们排出体外;海带可选择性杀灭或抑制肠道内能够产生致癌物的细菌,所含的纤维还能促进胆汁酸和胆固醇的排出;海带提取物对各种癌细胞有直接抑制作用;10、抗辐射:海带的提取物海带多糖因抑制免疫细胞凋亡而具有抗辐射作用;现代医学研究证实其提取物藻胶酸钠有止血作用,预防白血病、骨痛病、减少放性元素被肠道吸收。
本发明采用的技术方案如下:
一种黄秋葵、菌、藻组合物保健酒,它包括如下重量份数的组分:
(黄秋葵30-50份、菌15-35份、藻35-50份)组合的混合料30-45%,糯、糙米(1:1)55-70%。
本发明还公开了一种黄秋葵、菌、藻组合物保健酒的制备方法,包括如下工艺和步骤:
1)黄秋葵、菌、藻按配比称取,所述的黄秋葵采用绿色有机栽种的黄秋葵,所述的菌采用蛹虫草、猴头菇、茯苓、灵芝的任一种或组合,所述的藻采用螺旋藻(极大螺旋藻或钝顶螺旋藻)、紫菜、海带的任一种或组合;各原料混合粉碎60目过筛得到混合料(备用);
2)取配方量糯、糙米混合,清洗后浸泡8-12h,拌入上述步骤1的混合料;
3)对步骤2的混合原料蒸糊,冷却,糖化(接入糖化菌),发酵30天(接入酵母菌);
4)后酵:对上述发酵料再次加入酵母菌,发酵45天,压滤;
5)收取压滤液,沉淀3-4天,装缸,调和(勾兑),封存24个月即成成品酒,灌瓶包装即可。
本发明的优点是:本发明之保健酒非一般药酒,而是具有一定功能的可口饮料,既没有饮用普通白酒的辛辣刺激之感;习惯饮酒者喜欢,不习惯饮酒人也容易接受;适用范围较广,几乎涉及各种临床(内、外、妇、皮肤等多种常见病)相对于普通药物易服易吸收;可润肤养容、美容。
附图说明
附图是本发明的制备工艺流程图。
下面结合实施例对本发明做进一步的叙述。
具体实施方式
实施例,一种黄秋葵、菌、藻组合物保健酒,它包括如下重量份数的组分:
(黄秋葵30-50份、菌15-35份、藻35-50份)组合的混合料30-45%,糯、糙米(1:1)55-70%。
本实施例还公开了一种黄秋葵、菌、藻组合物保健酒的制备方法,包括如下工艺和步骤:
1)黄秋葵、菌、藻按配比称取,本实施例选用的黄秋葵采用绿色有机栽种的新鲜黄秋葵,本实施例选用的菌为蛹虫草,也可采用猴头菇、茯苓、灵芝的任一种或组合,本实施例选用的藻为钝顶螺旋藻,也可采用极大螺旋藻、紫菜、海带的任一种或组合;各原料混合粉碎60目过筛得到混合料(备用);
2)取配方量糯、糙米混合,清洗后浸泡8-12h,拌入上述步骤1的混合料;
3)对步骤2的混合原料蒸糊,冷却,糖化(接入糖化菌),发酵30天(接入酵母菌);
4)后酵:对上述发酵料再次加入酵母菌,发酵45天,压滤;
5)收取压滤液,沉淀3-4天,装缸,调和(勾兑),封存24个月即成成品酒,灌瓶包装即可。
本发明之保健酒非一般药酒,而是具有一定功能的可***醇饮料,清香爽口,适用各类人群服用,可润肤养容、美容;使人们在日常饮食的条件下,增加了多种营养物,既促进了健康,又起到了保健功能。
Claims (1)
1.一种黄秋葵、菌、藻组合物保健酒的制备方法,包括如下重量份数的组分:
黄秋葵30-50份、菌15-35份、藻35-50份组合的混合料30-45%,糯、糙米1:1 55-70%;
其特征在于,所述的黄秋葵、菌、藻组合物保健酒的制备方法,包括如下工艺和步骤:
1)黄秋葵、菌、藻按配比称取,所述的黄秋葵采用绿色有机栽种的黄秋葵,所述的菌采用蛹虫草,所述的藻采用极大螺旋藻;各原料混合粉碎60目过筛得到混合料;
2)取配方量糯、糙米混合,清洗后浸泡8-12h,拌入上述步骤1的混合料;
3)对步骤2的混合原料蒸糊,冷却,接入糖化菌糖化,接入酵母菌发酵30天;
4)后酵:对上述发酵料再次加入酵母菌,发酵45天,压滤;
5)收取压滤液,沉淀3-4天,装缸,调和勾兑,封存24个月即成成品酒,灌瓶包装即可。
Priority Applications (20)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610850966.3A CN106148106A (zh) | 2014-10-23 | 2014-10-23 | 黄秋葵、猴头菇、藻组合物保健酒的制备方法 |
CN201610850823.2A CN106148103A (zh) | 2014-10-23 | 2014-10-23 | 黄秋葵、菌、海带组合物保健酒的制备方法 |
CN201610850722.5A CN106190707A (zh) | 2014-10-23 | 2014-10-23 | 黄秋葵、灵芝、藻保健酒的制备方法 |
CN201610850780.8A CN106148102A (zh) | 2014-10-23 | 2014-10-23 | 一种黄秋葵、灵芝、藻组合物保健酒的制备方法 |
CN201610850822.8A CN106119017A (zh) | 2014-10-23 | 2014-10-23 | 黄秋葵、菌、藻组合物保健酒的制备方法 |
CN201610850905.7A CN106119020A (zh) | 2014-10-23 | 2014-10-23 | 一种黄秋葵、猴头菇、藻组合物保健酒的制备方法 |
CN201610850721.0A CN106148099A (zh) | 2014-10-23 | 2014-10-23 | 黄秋葵、菌、螺旋藻组合物保健酒的制备方法 |
CN201610850846.3A CN106148104A (zh) | 2014-10-23 | 2014-10-23 | 一种黄秋葵、蛹虫草、紫菜组合物保健酒的制备方法 |
CN201610850967.8A CN106148107A (zh) | 2014-10-23 | 2014-10-23 | 一种黄秋葵、蛹虫草、海带组合物保健酒的制备方法 |
CN201610850824.7A CN106190709A (zh) | 2014-10-23 | 2014-10-23 | 一种黄秋葵、菌、螺旋藻组合物保健酒的制备方法 |
CN201610850725.9A CN106190708A (zh) | 2014-10-23 | 2014-10-23 | 一种黄秋葵、蛹虫草、藻保健酒的制备方法 |
CN201610850848.2A CN106119018A (zh) | 2014-10-23 | 2014-10-23 | 一种黄秋葵、猴头菇、藻保健酒的制备方法 |
CN201610850757.9A CN106148101A (zh) | 2014-10-23 | 2014-10-23 | 黄秋葵、灵芝、螺旋藻组合物保健酒的制备方法 |
CN201610850850.XA CN106119019A (zh) | 2014-10-23 | 2014-10-23 | 一种黄秋葵、灵芝、螺旋藻组合物保健酒的制备方法 |
CN201610850847.8A CN106148105A (zh) | 2014-10-23 | 2014-10-23 | 黄秋葵、茯苓、藻保健酒的制备方法 |
CN201610850723.XA CN106148100A (zh) | 2014-10-23 | 2014-10-23 | 一种黄秋葵、灵芝、藻保健酒的制备方法 |
CN201610850724.4A CN106119016A (zh) | 2014-10-23 | 2014-10-23 | 一种黄秋葵、茯苓、藻保健酒的制备方法 |
CN201410571574.4A CN104450374B (zh) | 2014-10-23 | 一种黄秋葵、菌、藻组合物保健酒及其制备方法 | |
CN201610850624.1A CN106148098A (zh) | 2014-10-23 | 2014-10-23 | 一种黄秋葵、蛹虫草、藻组合物保健酒的制备方法 |
CN201610850969.7A CN106190710A (zh) | 2014-10-23 | 2014-10-23 | 一种黄秋葵、茯苓、螺旋藻组合物保健酒的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410571574.4A CN104450374B (zh) | 2014-10-23 | 一种黄秋葵、菌、藻组合物保健酒及其制备方法 |
Related Child Applications (19)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610850724.4A Division CN106119016A (zh) | 2014-10-23 | 2014-10-23 | 一种黄秋葵、茯苓、藻保健酒的制备方法 |
CN201610850824.7A Division CN106190709A (zh) | 2014-10-23 | 2014-10-23 | 一种黄秋葵、菌、螺旋藻组合物保健酒的制备方法 |
CN201610850969.7A Division CN106190710A (zh) | 2014-10-23 | 2014-10-23 | 一种黄秋葵、茯苓、螺旋藻组合物保健酒的制备方法 |
CN201610850780.8A Division CN106148102A (zh) | 2014-10-23 | 2014-10-23 | 一种黄秋葵、灵芝、藻组合物保健酒的制备方法 |
CN201610850823.2A Division CN106148103A (zh) | 2014-10-23 | 2014-10-23 | 黄秋葵、菌、海带组合物保健酒的制备方法 |
CN201610850624.1A Division CN106148098A (zh) | 2014-10-23 | 2014-10-23 | 一种黄秋葵、蛹虫草、藻组合物保健酒的制备方法 |
CN201610850848.2A Division CN106119018A (zh) | 2014-10-23 | 2014-10-23 | 一种黄秋葵、猴头菇、藻保健酒的制备方法 |
CN201610850967.8A Division CN106148107A (zh) | 2014-10-23 | 2014-10-23 | 一种黄秋葵、蛹虫草、海带组合物保健酒的制备方法 |
CN201610850850.XA Division CN106119019A (zh) | 2014-10-23 | 2014-10-23 | 一种黄秋葵、灵芝、螺旋藻组合物保健酒的制备方法 |
CN201610850846.3A Division CN106148104A (zh) | 2014-10-23 | 2014-10-23 | 一种黄秋葵、蛹虫草、紫菜组合物保健酒的制备方法 |
CN201610850822.8A Division CN106119017A (zh) | 2014-10-23 | 2014-10-23 | 黄秋葵、菌、藻组合物保健酒的制备方法 |
CN201610850905.7A Division CN106119020A (zh) | 2014-10-23 | 2014-10-23 | 一种黄秋葵、猴头菇、藻组合物保健酒的制备方法 |
CN201610850757.9A Division CN106148101A (zh) | 2014-10-23 | 2014-10-23 | 黄秋葵、灵芝、螺旋藻组合物保健酒的制备方法 |
CN201610850847.8A Division CN106148105A (zh) | 2014-10-23 | 2014-10-23 | 黄秋葵、茯苓、藻保健酒的制备方法 |
CN201610850722.5A Division CN106190707A (zh) | 2014-10-23 | 2014-10-23 | 黄秋葵、灵芝、藻保健酒的制备方法 |
CN201610850966.3A Division CN106148106A (zh) | 2014-10-23 | 2014-10-23 | 黄秋葵、猴头菇、藻组合物保健酒的制备方法 |
CN201610850721.0A Division CN106148099A (zh) | 2014-10-23 | 2014-10-23 | 黄秋葵、菌、螺旋藻组合物保健酒的制备方法 |
CN201610850723.XA Division CN106148100A (zh) | 2014-10-23 | 2014-10-23 | 一种黄秋葵、灵芝、藻保健酒的制备方法 |
CN201610850725.9A Division CN106190708A (zh) | 2014-10-23 | 2014-10-23 | 一种黄秋葵、蛹虫草、藻保健酒的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104450374A CN104450374A (zh) | 2015-03-25 |
CN104450374B true CN104450374B (zh) | 2017-01-04 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101695376B (zh) | 预防糖尿病的保健食品 | |
CN104479946A (zh) | 黄秋葵、菌、藻植物组合物制作营养露酒的方法 | |
CN102178183A (zh) | 一种五豆综合营养食品 | |
CN102940153A (zh) | 一种改善肉质、蛋质的家禽饲料 | |
CN104479964A (zh) | 一种黄秋葵、菌、藻保健酒及其制备方法 | |
CN106937741A (zh) | 一种脱脂亚麻籽粉防癌抗癌健康减肥法及其制备方法 | |
CN104473286A (zh) | 黄秋葵、菌、藻合成的固体(功能)饮料及其制备方法 | |
CN108497474A (zh) | 一种全植物药食糊 | |
KR20100082689A (ko) | 월드 인삼 조성물과 그 제조방법 | |
CN110638038A (zh) | 一种用于控制高血糖的医学配方营养代餐粉及其制备方法 | |
CN104430720A (zh) | 黄秋葵、菌、藻植物组合物制作功能性饼干的方法 | |
CN104382007B (zh) | 一种功能性胶囊及其制备方法 | |
CN104450374B (zh) | 一种黄秋葵、菌、藻组合物保健酒及其制备方法 | |
CN103689561A (zh) | 一种有助于降脂减肥的养生保健食品配方及其制备方法 | |
CN104432305A (zh) | 一种食疗功能饮料及其制备方法 | |
KR20100082688A (ko) | 월드 홍삼 조성물과 그 제조방법 | |
CN105361149A (zh) | 一种青稞虫草糁子营养粉及其制备方法 | |
CN106190709A (zh) | 一种黄秋葵、菌、螺旋藻组合物保健酒的制备方法 | |
CN104472816A (zh) | 黄秋葵、菌、藻植物组合物制作功能巧克力的方法 | |
CN108902731A (zh) | 一种健脾养胃、促进儿童智力发育及身体成长的面条及其制备方法 | |
KR20100072144A (ko) | 월드 홍삼 조성물과 그 제조방법 | |
CN104430719A (zh) | 黄秋葵、菌、藻植物组合物制作保康酥的方法 | |
CN104473065A (zh) | 一种黄秋葵、菌、藻组合物营养料及其制备方法 | |
CN104381852A (zh) | 黄秋葵、菌、藻植物组合物制作功能性挂面的方法 | |
CN104473066A (zh) | 一种食疗(功能)营养料及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20170104 Termination date: 20171023 |